Talha Munir
IGHV Unmutated Status, Low Tumor Lysis Risk Disease and BRAF Mutated Status Are Predictors for Early MRD Responders Treated with MRD Defined Ibrutinib with Venetoclax: Report of the UK NCRI FLAIR Study
Munir, Talha; Varghese, Abraham Mullasseril; Bloor, Adrian; Allsup, David; Cwynarski, Kate; Pettitt, Andrew; Paneesha, Shankara; Fox, Christopher P; Eyre, Toby A.; Forconi, Francesco; Elmusharaf, Nagah; Kennedy, Ben; Gribben, Prof. John G.; Pemberton, Nicholas; Sheehy, Oonagh; Preston, Gavin; Schuh, Anna; Hockaday, Anna; Cairns, David A.; Jackson, Sharon; Greatorex, Natasha; Girvan, Sean; Bell, Sue; Stones, David; McWhirter, Nichola; Dalal, Surita; Rawstron, Andrew; Patten, Piers; Hillmen, Peter
Authors
Abraham Mullasseril Varghese
Adrian Bloor
Professor David Allsup D.J.Allsup@hull.ac.uk
Professor of Haematology
Kate Cwynarski
Andrew Pettitt
Shankara Paneesha
Christopher P Fox
Toby A. Eyre
Francesco Forconi
Nagah Elmusharaf
Ben Kennedy
Prof. John G. Gribben
Nicholas Pemberton
Oonagh Sheehy
Gavin Preston
Anna Schuh
Anna Hockaday
David A. Cairns
Sharon Jackson
Natasha Greatorex
Sean Girvan
Sue Bell
David Stones
Nichola McWhirter
Surita Dalal
Andrew Rawstron
Piers Patten
Peter Hillmen
Citation
Munir, T., Varghese, A. M., Bloor, A., Allsup, D., Cwynarski, K., Pettitt, A., Paneesha, S., Fox, C. P., Eyre, T. A., Forconi, F., Elmusharaf, N., Kennedy, B., Gribben, P. J. G., Pemberton, N., Sheehy, O., Preston, G., Schuh, A., Hockaday, A., Cairns, D. A., Jackson, S., …Hillmen, P. (2024, December). IGHV Unmutated Status, Low Tumor Lysis Risk Disease and BRAF Mutated Status Are Predictors for Early MRD Responders Treated with MRD Defined Ibrutinib with Venetoclax: Report of the UK NCRI FLAIR Study. Presented at 66th American Society of Haematology Annual Meeting, San Diego
Presentation Conference Type | Conference Abstract |
---|---|
Conference Name | 66th American Society of Haematology Annual Meeting |
Start Date | Dec 7, 2024 |
End Date | Dec 10, 2024 |
Acceptance Date | Nov 5, 2024 |
Online Publication Date | Nov 5, 2024 |
Publication Date | Nov 5, 2024 |
Deposit Date | Dec 16, 2024 |
Publicly Available Date | Nov 6, 2025 |
Journal | Blood |
Print ISSN | 0006-4971 |
Publisher | American Society of Hematology |
Peer Reviewed | Peer Reviewed |
Volume | 144 |
Issue | Supplement 1 |
Pages | 585-585 |
DOI | https://doi.org/10.1182/blood-2024-211449 |
Public URL | https://hull-repository.worktribe.com/output/4964025 |
Files
This file is under embargo until Nov 6, 2025 due to copyright reasons.
Contact D.J.Allsup@hull.ac.uk to request a copy for personal use.
You might also like
Network meta-analysis of upfront fixed-duration therapies in chronic lymphocytic leukemia
(2024)
Journal Article
Epcoritamab in B-cell malignancies: current status and prospects
(2024)
Journal Article
Downloadable Citations
About Repository@Hull
Administrator e-mail: repository@hull.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search